Caption Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,439
Closed -$16.2K 2036
2026
Q1
$13.3K Sell
2,439
-5,160
-68% -$29K ﹤0.01% 1464
2025
Q4
$53.2K Sell
7,599
-22,401
-75% -$175K ﹤0.01% 1465
2025
Q3
$232K Buy
+30,000
New +$234K ﹤0.01% 1444
2024
Q3
Sell
-8,000
Closed -$66.2K 1587
2024
Q2
$78.2K Buy
+8,000
New +$97.6K ﹤0.01% 1036
2022
Q2
Sell
-7,500
Closed -$541K 1822
2022
Q1
$541K Sell
7,500
-1,800
-19% -$130K 0.01% 1125
2021
Q4
$854K Sell
9,300
-13,600
-59% -$1.63M 0.01% 1102
2021
Q3
$2.9M Buy
22,900
+18,092
+376% +$2.63M 0.03% 631
2021
Q2
$800K Buy
+4,808
New +$779K 0.01% 952
2021
Q1
Sell
-2,000
Closed -$464K 1385
2020
Q4
$400K Sell
2,000
-7,000
-78% -$1.42M 0.01% 769
2020
Q3
$1.97M Buy
9,000
+8,900
+8,900% +$1.88M 0.05% 427
2020
Q2
$19K Sell
100
-400
-80% -$70.1K ﹤0.01% 883
2020
Q1
$78K Sell
500
-13,100
-96% -$1.52M ﹤0.01% 778
2019
Q4
$1.14M Buy
13,600
+7,200
+113% +$548K 0.04% 475
2019
Q3
$434K Sell
6,400
-4,000
-38% -$263K 0.02% 504
2019
Q2
$691K Buy
+10,400
New +$606K 0.03% 431

Other funds holding TDOC

Caption Management's TDOC Position: Q2 2026 in Review

Caption Management sold out of Teladoc Health (TDOC) in Q2 2026, closing a stake of 2,439 shares — an estimated $16.2K sold.

Caption Management first reported a position in TDOC in Q2 2019 and held it in 15 quarters. The position peaked at $2.9M in Q3 2021. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Caption Management reported no remaining Teladoc Health position as of Q2 2026 after selling out during the quarter.
  • Caption Management sold 2,439 Teladoc Health shares in Q2 2026, an estimated $16.2K.
  • Caption Management first reported a position in Teladoc Health in Q2 2019 and held it in 15 quarters.
  • Caption Management's Teladoc Health position peaked at $2.9M in Q3 2021.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.